Related Experiment Video
Updated: Jun 12, 2026
09:36
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
Neuro-oncology Burden in Developing Countries: A Retrospective Cost-Analysis Study
Said Nassier Said Alsenani1, Rawan Nasser Almaskari1, Yusra Abid Shah2
1The Medical City for Military & Security Services, Muscat, Sultanate of Oman.
The Gulf Journal of Oncology
|June 11, 2026
Summary
The economic burden of brain tumour management in Oman is substantial, with significant costs for diagnostic imaging and laboratory tests. Further research is needed to assess the total healthcare impact.
Area of Science:
- Neuro-oncology
- Health Economics
- Medical Research
Background:
- Brain tumours represent a considerable economic strain on individuals and healthcare infrastructures.
- Understanding the financial implications of brain tumour care is crucial for resource allocation and policy development.
Purpose of the Study:
- To investigate the financial costs associated with the management of brain tumours.
- To evaluate the impact of brain tumour treatment on the healthcare system in Oman.
Main Methods:
- A retrospective observational study was conducted involving 280 patients diagnosed with brain tumours.
- Data were collected from medical records at Khoula Hospital, Oman, including demographics, tumour type, diagnosis, treatment, investigation costs, and hospital stay duration.
Main Results:
- The average cost for imaging and laboratory investigations was $276,293.33. Imaging costs were $208,168.7, and laboratory tests cost $68,124.63.
- CT scans were the most costly imaging, while Renal Function Tests (RFT), Measles IgM Antibody Test (MDR), and Methicillin-resistant Staphylococcus aureus (MRSA) screening were the most expensive laboratory tests.
- Meningioma was the most frequent diagnosis (18%), with an average hospital stay of 16 days.
Conclusions:
- The management of brain tumours in Oman incurs significant financial costs.
- Further comprehensive research is essential to determine the complete economic burden, encompassing surgical and non-surgical treatment expenses.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:08Prevalence and Incidence
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...